From Cardiovascular Research, Brigham and Women's Hospital, Boston,
Mass.
Correspondence to Victor J. Dzau, MD, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115.
Abstract
Abstract—Entry into and progression
of vascular cells through the cell cycle is considered a key event in
vascular proliferative diseases. Multiple growth factors and
cytokines have been found to regulate vascular cell
proliferation. However, the machinery regulating cell cycle
represents the "final common pathway" of these signaling
cascades and thus provides an attractive therapeutic target for the
prevention of vascular proliferative diseases. This review focuses on
the current understanding of the regulation of the cell cycle machinery
especially as it relates to vascular cell biology and the feasibility
of targeting cell cycle for the prevention of restenosis after
balloon angioplasty and bypass vein graft disease.
© 1998 American Heart Association, Inc.
Current Perspective
Cell Cycle Progression
New Therapeutic Target for Vascular Proliferative Disease
Key Words: atherosclerosis • restenosis • bypass • genes • molecular biology
This article has been cited by other articles:
 |
|
 |
|
  S. Wang and Y. Li Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2075 - H2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Sedding, M. Trobs, F. Reich, G. Walker, L. Fink, W. Haberbosch, W. Rau, H. Tillmanns, K. T. Preissner, R. M. Bohle, et al. 3-Deazaadenosine Prevents Smooth Muscle Cell Proliferation and Neointima Formation by Interfering With Ras Signaling Circ. Res., May 22, 2009; 104(10): 1192 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dumont, M. Zureik, C. Bauters, M.-C. Grupposo, D. Cottel, M. Montaye, M. Hamon, P. Ducimetiere, P. Amouyel, and T. Brousseau Association of OAZ1 Gene Polymorphisms With Subclinical and Clinical Vascular Events Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Morrissey Biological Treatment of Vein Grafts and Stents in Lower-Extremity Arterial Reconstruction Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 293 - 297. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Yang, J. Ge, H. Liu, K. Zhao, X. Liu, X. Qu, W. Li, Y. Huang, A. Sun, and Y. Zou Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model Cardiovasc Res, December 1, 2006; 72(3): 483 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fajadet, W. Wijns, G.-J. Laarman, K.-H. Kuck, J. Ormiston, T. Munzel, J. J. Popma, P. J. Fitzgerald, R. Bonan, R. E. Kuntz, et al. Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial Circulation, August 22, 2006; 114(8): 798 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Barchiesi, E. K. Jackson, J. Fingerle, D. G. Gillespie, B. Odermatt, and R. K. Dubey 2-Methoxyestradiol, an Estradiol Metabolite, Inhibits Neointima Formation and Smooth Muscle Cell Growth via Double Blockade of the Cell Cycle Circ. Res., August 4, 2006; 99(3): 266 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Touchard and R. S. Schwartz Preclinical Restenosis Models: Challenges and Successes Toxicol Pathol, January 1, 2006; 34(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 PREVENT IV Investigators Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial JAMA, November 16, 2005; 294(19): 2446 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ollinger, M. Bilban, A. Erat, A. Froio, J. McDaid, S. Tyagi, E. Csizmadia, A. V. Graca-Souza, A. Liloia, M. P. Soares, et al. Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation Circulation, August 16, 2005; 112(7): 1030 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hata, J. A. Petrofski, J. N. Schroder, M. L. Williams, S. H. Timberlake, A. Pippen, M. T. Corwin, A. K. Solan, A. Jakoi, T. R. Gehrig, et al. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1405 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fasciano, R. C. Patel, I. Handy, and C. V. Patel Regulation of Vascular Smooth Muscle Proliferation by Heparin: INHIBITION OF CYCLIN-DEPENDENT KINASE 2 ACTIVITY BY p27kip1 J. Biol. Chem., April 22, 2005; 280(16): 15682 - 15689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martinez-Gonzalez and L. Badimon The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells Cardiovasc Res, February 15, 2005; 65(3): 609 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, X.-L. Niu, A. M. Pippen, B. H. Annex, and C. D. Kontos Adenovirus-Mediated Intraarterial Delivery of PTEN Inhibits Neointimal Hyperplasia Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 354 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blaschke, O. Leppanen, Y. Takata, E. Caglayan, J. Liu, M. C. Fishbein, K. Kappert, K. I. Nakayama, A. R. Collins, E. Fleck, et al. Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries Circ. Res., December 10, 2004; 95(12): e110 - e123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Banai, S.D. Gertz, L. Gavish, M. Chorny, L. S. Perez, G. Lazarovichi, M. Ianculuvich, M. Hoffmann, M. Orlowski, G. Golomb, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries Cardiovasc Res, October 1, 2004; 64(1): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.G Melo, M Gnecchi, A.S Pachori, K Wang, and V.J Dzau Gene- and cell-based therapies for cardiovascular diseases: current status and future directions Eur. Heart J. Suppl., September 1, 2004; 6(suppl_E): E24 - E35. [Abstract] [Full Text]
|
|
|
|
|
|
D.-F. Guo, V. Tardif, K. Ghelima, J. S. D. Chan, J. R. Ingelfinger, X. Chen, and I. Chenier A Novel Angiotensin II Type 1 Receptor-associated Protein Induces Cellular Hypertrophy in Rat Vascular Smooth Muscle and Renal Proximal Tubular Cells J. Biol. Chem., May 14, 2004; 279(20): 21109 - 21120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lucchesi Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. Focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation" Am J Physiol Cell Physiol, March 1, 2004; 286(3): C480 - C481. [Full Text] [PDF]
|
|
|
|
|
|
M. O'Sullivan, S. D Scott, N. McCarthy, N. Figg, L. M Shapiro, P. Kirkpatrick, and M. R Bennett Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy Cardiovasc Res, December 1, 2003; 60(3): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Springer and A. Fischer Substance P-induced pulmonary vascular remodelling in precision cut lung slices Eur. Respir. J., October 1, 2003; 22(4): 596 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Taylor and C. A. McNamara Regulation of Vascular Smooth Muscle Cell Growth: Targeting the Final Common Pathway Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1717 - 1720. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sousa, P. W. Serruys, and M. A. Costa New Frontiers in Cardiology: Drug-Eluting Stents: Part I Circulation, May 6, 2003; 107(17): 2274 - 2279. [Full Text] [PDF]
|
|
|
|
 |
|
 U. G. B. Haider, D. Sorescu, K. K. Griendling, A. M. Vollmar, and V. M. Dirsch Resveratrol Increases Serine15-Phosphorylated but Transcriptionally Impaired p53 and Induces a Reversible DNA Replication Block in Serum-Activated Vascular Smooth Muscle Cells Mol. Pharmacol., April 1, 2003; 63(4): 925 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Bornfeldt The Cyclin-Dependent Kinase Pathway Moves Forward Circ. Res., March 7, 2003; 92(4): 345 - 347. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Morice A new era in the treatment of coronary disease? Eur. Heart J., February 1, 2003; 24(3): 209 - 211. [Full Text] [PDF]
|
|
|
|
|
|
P.O Bonetti, L.O Lerman, C Napoli, and A Lerman Statin effects beyond lipid lowering--are they clinically relevant? Eur. Heart J., February 1, 2003; 24(3): 225 - 248. [Full Text] [PDF]
|
|
|
|
|
|
U. Kelkenberg, A. H. Wagner, J. Sarhaddar, M. Hecker, and H. E. von der Leyen CCAAT/Enhancer-Binding Protein Decoy Oligodeoxynucleotide Inhibition of Macrophage-Rich Vascular Lesion Formation in Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 949 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Peyton, S. V. Reyna, G. B. Chapman, D. Ensenat, X.-m. Liu, H. Wang, A. I. Schafer, and W. Durante Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth Blood, May 29, 2002; 99(12): 4443 - 4448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang and C. D. Kontos Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTEN Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 745 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Behrens, E. M. Gordon, L. Li, P. X. Liu, Z. Chen, H. Peng, L. La Bree, W. F. Anderson, F. L. Hall, and P. J. McDonnell Retroviral Gene Therapy Vectors for Prevention of Excimer Laser-Induced Corneal Haze Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 968 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, M. Fu, X. Zhu, Y. Xiao, Y. Mou, H. Zheng, M. A. Akinbami, Q. Wang, and Y. E. Chen Peroxisome Proliferator-activated Receptor delta Is Up-regulated during Vascular Lesion Formation and Promotes Post-confluent Cell Proliferation in Vascular Smooth Muscle Cells J. Biol. Chem., March 22, 2002; 277(13): 11505 - 11512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhan, S. Kim, H. Yasumoto, M. Namba, H. Miyazaki, and H. Iwao Effects of Dominant-Negative c-Jun on Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 82 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto and J. K. Liao Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1712 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Suzuki, G. Kopia, S.-i. Hayashi, L. R. Bailey, G. Llanos, R. Wilensky, B. D. Klugherz, G. Papandreou, P. Narayan, M. B. Leon, et al. Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model Circulation, September 4, 2001; 104(10): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Miano and B. C. Berk Retinoids: New Insight Into Smooth Muscle Cell Growth Inhibition Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 724 - 726. [Full Text] [PDF]
|
|
|
|
|
|
S. Wakino, U. Kintscher, S. Kim, S. Jackson, F. Yin, S. Nagpal, R. A. S. Chandraratna, W. A. Hsueh, and R. E. Law Retinoids Inhibit Proliferation of Human Coronary Smooth Muscle Cells by Modulating Cell Cycle Regulators Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 746 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Hsueh, S. Jackson, and R. E. Law Control of Vascular Cell Proliferation and Migration by PPAR-{gamma}: A new approach to the macrovascular complications of diabetes Diabetes Care, February 1, 2001; 24(2): 392 - 397. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz Gene Therapy for Cardiovascular Disease Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300. [Abstract] [PDF]
|
|
|
|
|
|
D. E. Marra, T. Simoncini, and J. K. Liao Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1 Circulation, October 24, 2000; 102(17): 2124 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Peppel, A. Jacobson, X. Huang, J. P. Murray, M. Oppermann, and N. J. Freedman Overexpression of G Protein-Coupled Receptor Kinase-2 in Smooth Muscle Cells Attenuates Mitogenic Signaling via G Protein-Coupled and Platelet-Derived Growth Factor Receptors Circulation, August 15, 2000; 102(7): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kintscher, S. Wakino, S. Kim, S. M. Jackson, E. Fleck, W. A. Hsueh, and R. E. Law Doxazosin Inhibits Retinoblastoma Protein Phosphorylation and G1->S Transition in Human Coronary Smooth Muscle Cells Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1216 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Chapman, W. Durante, J. D. Hellums, and A. I. Schafer Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H748 - H754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: an update Cardiovasc Res, December 1, 1999; 44(3): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-I. Miyatake, H. Yukawa, H. Toda, N. Matsuoka, R. Takahashi, N. Hashimoto, and C. D. Kontos Inhibition of Rat Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Recombinant Replication-Competent Herpes Simplex Virus • Editorial Comment Stroke, November 1, 1999; 30 (11): 2431 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Durmowicz and K. R. Stenmark Mechanisms of Structural Remodeling in Chronic Pulmonary Hypertension Pediatr. Rev., November 1, 1999; 20(11): e91 - e102. [Full Text] [PDF]
|
|
|
|
|
|
U. Laufs, D. Marra, K. Node, and J. K. Liao 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27Kip1 J. Biol. Chem., July 30, 1999; 274(31): 21926 - 21931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mano, Z. Luo, S. L. Malendowicz, T. Evans, and K. Walsh Reversal of GATA-6 Downregulation Promotes Smooth Muscle Differentiation and Inhibits Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery Circ. Res., April 2, 1999; 84(6): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. B. Pahl, X.-D. Yan, Y. K. Hodges, E. A. Rosenthal, M. A. Horwitz, and L. D. Horwitz An Exochelin of Mycobacterium tuberculosis Reversibly Arrests Growth of Human Vascular Smooth Muscle Cells in Vitro J. Biol. Chem., June 2, 2000; 275(23): 17821 - 17826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wakino, U. Kintscher, S. Kim, F. Yin, W. A. Hsueh, and R. E. Law Peroxisome Proliferator-activated Receptor gamma Ligands Inhibit Retinoblastoma Phosphorylation and G1right-arrow S Transition in Vascular Smooth Muscle Cells J. Biol. Chem., July 14, 2000; 275(29): 22435 - 22441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Reis, M. Roque, H. Dansky, J. T. Fallon, J. J. Badimon, C. Cordon-Cardo, S. J. Shiff, and E. A. Fisher Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice PNAS, November 7, 2000; 97(23): 12764 - 12769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
PREVENT IV Investigators Efficacy and Safety of Edifoligide, an E2F Transcription Factor Decoy, for Prevention of Vein Graft Failure Following Coronary Artery Bypass Graft Surgery: PREVENT IV: A Randomized Controlled Trial JAMA, November 16, 2005; 294(19): 2446 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Liistro, G. Stankovic, C. Di Mario, T. Takagi, A. Chieffo, S. Moshiri, M. Montorfano, M. Carlino, C. Briguori, P. Pagnotta, et al. First Clinical Experience With a Paclitaxel Derivate-Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome Circulation, April 23, 2002; 105(16): 1883 - 1886. [Abstract] [Full Text] [PDF]
|
|